| Literature DB >> 19549291 |
Tzong-Yi Lee1, Justin Bo-Kai Hsu, Wen-Chi Chang, Ting-Yuan Wang, Po-Chiang Hsu, Hsien-Da Huang.
Abstract
BACKGROUND: Protein Post-Translational Modification (PTM) plays an essential role in cellular control mechanisms that adjust protein physical and chemical properties, folding, conformation, stability and activity, thus also altering protein function.Entities:
Year: 2009 PMID: 19549291 PMCID: PMC2713254 DOI: 10.1186/1756-0500-2-111
Source DB: PubMed Journal: BMC Res Notes ISSN: 1756-0500
Figure 1The system architecture of the knowledge base for protein translational modification. It comprises the three major components: integration of external experimental PTM databases, learning and prediction of 20 types of PTM, and annotations of PTM knowledge (more details in the text).
The statistics of experimental PTM sites and putative PTM sites in this study.
| Phosphorylation | Serine, threonine, tyrosine, and histidine | 31,363 | 36,080 | 1,815,472 |
| N-linked Glycosylation | Asparagine and lysine | 3,264 | 77,571 | 179,955 |
| O-linked Glycosylation | Lysine, praline, serine, threonine, and tyrosine | 1,896 | 2,558 | 386,545 |
| C-linked Glycosylation | Tryptophan | 53 | 52 | 4,015 |
| Acetylation | N-terminal of some residues and side chain of lysine or cysteine | 2,080 | 5,143 | 1,206 |
| Amidation | Generally at the C-terminal of a mature active peptide after oxidative cleavage of last glycine | 2,150 | 1,117 | 24,352 |
| Hydroxylation | Generally of asparagine, aspartate, proline or lysine | 1,033 | 1,074 | 9,743 |
| Methylation | Generally of N-terminal phenylalanine, side chain of lysine, arginine, histidine, asparagine or glutamate, and C-terminal cysteine | 746 | 2,846 | 18,716 |
| Pyrrolidone Carboxylic Acid | N-terminal glutamine which has formed an internal cyclic lactam. | 598 | 584 | 12,322 |
| Gamma-Carboxyglutamic Acid | Glutamate | 371 | 361 | 1,924 |
| Farnesylation | Cysteine | 61 | 216 | 5,349 |
| Myristoylation | Glycine | 108 | 765 | 10,998 |
| N-Palmitoylation | Cysteine | 33 | 1,279 | 6,554 |
| S-Palmitoylation | Cysteine | 177 | 2,303 | 21,287 |
| Geranyl-geranylation | Cysteine | 47 | 819 | 14,317 |
| S-diacylglycerol cysteine | Cysteine | 36 | 1,529 | 8,977 |
| GPI anchoring | C-terminal asparagine, asparate, and serine | 27 | 681 | - |
| Deamidation | Amidated asparagine and glutamine (needs to be followed by a G) | 38 | 26 | 2,022 |
| Sulfation | Serine, threonine, and tyrosine | 196 | 626 | 15,654 |
| Sumoylation | Lysine | 77 | 259 | 10,342 |
| Ubiquitylation | Lysine | 286 | 516 | 8,865 |
| ADP-ribosylation | Arginine | 3 | 203 | - |
| Formylation | Of the N-terminal methionine | 28 | 35 | - |
| Citrullination | Arginine | 27 | 91 | - |
| Nitration | Tyrosine | 47 | 5 | 1,432 |
| Bromination | Tryptophan | 18 | 3 | - |
| FAD | O-8alpha-FAD tyrosine, Pros-8alpha-FAD histidine, S-8alpha-FAD cysteine, and Tele-8alpha-FAD histidine | 12 | 116 | - |
| S-nitrosylation | Cysteine | 9 | 93 | - |
| Others | 1049 | 2,958 | - | |
| Total | 45,833 | 139,909 | 2,560,047 | |
The enhanced features in this expanding PTM database (dbPTM 2.0).
| Protein entry | UniProtKB/Swiss-Prot (release 46) | UniProtKB/Swiss-Prot (release 55) |
| Experimental PTM resource | UniProtKB/Swiss-Prot, Phospho.ELM, and O-GLYCBASE | UniProtKB/Swiss-Prot, Phospho.ELM, PHOSIDA, HPRD, O-GLYCBASE, and UbiProt |
| Computationally predicted PTMs | Phosphorylation, glycosylation, and sulfation | About 25 types of PTM (phosphorylation, glycosylation, sulfation, acetylation, methylation, sumoylation, hydroxylation, etc.) |
| Protein structure | Protein Data Bank (PDB) | Protein Data Bank (PDB) |
| PTM annotation | RESID (373 PTM annotations) | RESID (431 PTM annotations) |
| Structural investigation of PTM sites | - | Solvent accessibility, secondary structure and intrinsic disorder region |
| Kinase family annotation | - | KinBase |
| Protein domain | InterPro | InterPro |
| Protein variation | Swiss-Prot and Ensembl | Swiss-Prot and Ensembl |
| Site-specific PTM literature | - | Extracting the PTM-related literatures from UniProtKB/Swiss-Prot, Phospho.ELM, HPRD, O-GLYCBASE, and UbiProt |
| Substrate specificity | - | Amino acid frequency, solvent accessibility, secondary structure and disorder region surrounding modified sites |
| Evolutionary conservation of PTM sites | - | COG and ClustalW |
| PTM benchmark set for computational studies | - | Providing the benchmark for constructing PTM test set to compare the predictive performance of prediction tools |
| Relationship between PTM and subcellular localization | - | Analyzing the relationship between PTM and subcellular localization |
| Graphical visualization | PTM, solvent accessibility, secondary structure, protein variation, protein domain, and tertiary structure | PTM, solvent accessibility, secondary structure, protein variation, protein domain, tertiary structure, orthologous conserved regions, substrate site specificity and protein interaction network |
Figure 2A part of result page on the web interface. An example of graphical presentation of PTM sites and the structural characteristics of human protein IRS1.
Figure 3An illustrative example to show the catalytic specificity of acetyllysine.